top of page

ABOUT US

ADVANCED OPTICAL SENSING SOLUTIONS FOR A HEALTHIER AND SAFER WORLD.

Our goal for Halo is to create a new standard of care in POC and at-home testing by offering assay manufacturers a turnkey solution for the deployment and use of rapid tests.

MEET THE TEAM

Founded in 2013 as an MIT “Tough Tech” spinout, we’ve applied our expertise in optical sensing to develop the Halo Platform. Headquartered in Watertown, Massachusetts, the HALO team features 14 scientists, engineers, and business leaders designing and implementing innovative solutions for healthier people and a safer world.

Jason Cox, Ph.D.

Chief Executive Officer

Robert Deans, Ph.D.

Chief Technology Officer

Eric Keller

Chief Strategy Officer

Joseph Walish, Ph.D.

Chief Product Owner

Mary Rose Durante

VP Business Operations

Joy Donohue

Sr. Director Marketing

Trey Lawrence

Product Owner

Gabriel Davis

Sr Software & Algo Eng.

Alex Petty

Scientist III

Brian Fratto, Ph.D.

Senior Scientist

Nicole Terry

Product Owner/ R&D Eng.

Emma Culver

Scientist II

Sean Hwang, Ph.D.

Test Engineer

Jill Bjorkman

Office Manager

SCROLL TO SEE

WHAT MAKES

HALO UNIQUE

Compliance testing should be repeatable with consistent outcomes and auditable results. 

SCROLL TO SEE

WHAT MAKES HALO UNIQUE

Halo provides assay manufacturers with a turnkey LFA reader solution to enable at-home and POC lab-quality diagnostics. 

Thoughtfully designed app reduces user error, enables consumer engagement and access to online marketplace for test purchase. 

Highly reliable and providing consistent outcomes, Halo is a portable, low-powered device designed to offer lab-quality diagnostics wherever they are needed. 

APR

April 25, 2023

 Jim Mahoney Joins C2Sense Board of Directors 

C2Sense, Inc., today announced that its Board of Directors has appointed Jim Mahoney, MBA, MMA as an independent director effective January 31, 2023. 

MAR

March 30, 2023

 C2Sense Welcomes Adam Behrens to Board of Directors 

C2Sense, Inc.,  announced the appointment of Adam Behrens, Ph.D., to its Board of Directors as an independent director effective January 31, 2023. 

MAR

March 8, 2023

Watertown, Mass., March 8, 2023 – C2Sense, Inc., today announced the appointment of the Honorable Andrew Weber to its Board of Directors effective January 31, 2023.

FEB

February 1, 2023

Digital innovation and connected diagnostics can help address global health disparities, but it is essential to ensure health governance advances alongside new technologies.

JAN

January 4, 2023

C2Sense, Inc., a technology company developing a suite of diagnostic products for healthcare, wellness and safety, announced today the successful second closing of its $8M Series B financing round with participation from new and existing investors.

DEC

December 6, 2022

Halo launches a platform-dedicated website​

NOV

November 2, 2022

Celebrating the first ever shipment of the Halo product!

OCT

October 23, 2022

Visit us at Booth #15036 at Pack Expo International - October 23 - 26 at McCormick Place, Chicago, IL USA. 

AUG

August 25, 2022

C2Sense, Inc., is a technology company developing a suite of diagnostic products for healthcare, wellness and safety.

APR

April 18, 2022

Halo™️ a Universal Fluorescence Reader Published in Frontiers in Public Health

C2Sense, Inc. has published a proof-of-concept study in Frontiers in Public Health demonstrating the sensitivity and specificity of its Halo™️ technology platform to detect SARS-CoV-2.

THE LATEST

HALO NEWS

Contact Us

Thanks for submitting!

Interested In:
bottom of page